SGLT2 inhibitors, also called gliflozins, are a class of
medications that inhibit reabsorption of glucose in the kidney and
therefore lower blood sugar. They act by inhibiting sodium-glucose
transport protein 2 (SGLT2). SGLT2 inhibitors are used in the
treatment of type 2 diabetes mellitus. This book is a concise guide
to the use of SGLT2 inhibitors for the treatment of diabetes.
Beginning with an overview of the evolution and physiology of SGLT2
inhibitors, the following sections cover the renal, cardiovascular,
and metabolic and haemodynamic effects of their use. Adverse
effects are also examined. The book concludes with detailed
discussion on SGLT2 inhibitor use as a preferred option for
management of type 2 diabetes, and currently emerging data for
their successful use for treatment of type 1 diabetes. Authored by
recognised experts in the field, the book provides clinicians with
the latest advances in the field, further enhanced by illustrations
and figures to assist learning. Key points Concise guide to use of
SGLT2 inhibitors for management of diabetes Covers common use for
treatment of type 2 diabetes as well as increasing use for type 1
diabetes In depth discussion on associated systemic effects Highly
illustrated with diagrams and figures
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
